COMPANY PROFILE

OncoOne

Explore full profile

OncoOne is a biotech start-up dedicated to develop innovative therapeutics to treat patients with solid tumors

Vienna, AustriaFounded 2018Biotech & Life Sciences

Valuation $50–100M Last recorded · 2020

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About OncoOne

OncoOne is a biotech startup dedicated to developing innovative therapeutics aimed at treating patients with solid tumors. Founded by three experts with extensive backgrounds in drug development and oncology research, the company operates in the biotechnology sector, specifically focusing on oncology. OncoOne serves patients with serious unmet medical needs in cancer treatment. The company's business model revolves around research and development (R&D) of anti-cancer medicines, with a particular emphasis on targeting the oxidized macrophage migration inhibitory factor (oxMIF). Revenue is generated through partnerships, licensing agreements, and potential future sales of their developed therapeutics. The market for OncoOne's products includes healthcare providers, pharmaceutical companies, and research institutions focused on oncology. The company aims to build a differentiated pipeline of potent therapeutics, leveraging its strong scientific foundation and strategic collaborations.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Vienna, Austria
Employees: 9
Open positions: None listed
Dealroom signal: 69.4/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Mar 2020	$14M	$57M	Austria Wirtschaftsservice	—
SUPPORT PROGRAM✓Other financing	Jul 2018	$0	—	accent	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

OncoOne website traffic

Latest recorded traffic for OncoOne is 70 monthly website visits, down 93.6% over the last three months. OncoOne's team declined 10% over the past year.

Latest monthly visits70 3-month web change-93.6% 1-year team growth-10%

Monthly website visitsFeb 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OHOssium HealthBuilding the world's first bone marrow bank to treat blood cancers	San Francisco, United States	Operational	104	$135M	$315M
SCScreenCellA provider of rare cell isolation solutions for medical and research applications	Paris, France	Operational
CPCorvus PharmaceuticalsClinical-stage biopharmaceutical company focused on the development of novel agents that target the immune system to treat patients with cancer	Burlingame, United States	Operational
BBBiond BiologicsInnovative immunotherapies and a pioneering intracellular delivery for biologics for the treatment of patients	Misgav Am, Israel	Operational
RTRTsafeEnsures safety and efficiency of radiation oncology treatments of cancer patients, in a personalized (patient-specific) manner	Athens, Greece	Operational
ABAkamis BioLeading company in developing cancer gene therapies	Abingdon, United Kingdom	Operational
ATAvila TherapeuticsFocused on the development of covalent drugs to treat cancer and other autoimmune diseases	Waltham, United States	Acquired
ANAnnoroadA leading developer and marketer on genomic innovation technologies for research and clinical market	Dongcheng District, China	Operational